Press release
Genetic Disorder Cluster Muscular Dystrophy Drug Development Pipeline Review, 2017 | Now Available at Researchmoz.us
This report provides an overview of the genetic disorders pipeline landscape, specifically focusing on muscular dystrophies. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Becker and Duchenne Muscular Dystrophy (BMD and DMD) and features dormant and discontinued projects. Both indications covered are inherited muscular dystrophies, a group of genetic, degenerative diseases primarily affecting voluntary muscles.
Browse Detail Report With Full TOC @ http://www.researchmoz.us/enquiry.php?type=S&repid=1070457
BMD, the first type of muscular dystrophy, leads to symptoms include pain and sensation, difficulty with running, hopping, and jumping, toe walking, breathing problems, cognitive problems and frequent falls. DMD is a condition which causes muscle weakness, and is an X-linked disorder. The gene for DMD is present on the X chromosome. It codes for a protein named dystrophin. Dystrophin is essential for providing structural support inside muscle cells. Symptoms usually appear before age 6 and may appear as early as infancy. They include fatigue, learning difficulties, intellectual disability, muscle weakness and progressive difficulty walking.
The size of these two pipelines ranges from just six in BMD to 108 in DMD. The majority of pipeline products for DMD target dystrophin which, as mentioned, is the causative gene for the disease. However, a number of products act on other molecular targets such as growth differentiation factor 8, nuclear factor kappa B and utrophin. The first two of these make up the pipeline for BMD, along with forkhead box protein 1B.
Browse Detail Report With Full TOC @ http://www.researchmoz.us/genetic-disorder-cluster-muscular-dystrophy-drug-development-pipeline-review-2017-report.html
Scope
- Which companies are the most active within the pipeline for genetic disorder therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of genetic disorder therapeutics?
Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1070457
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Genetic Disorder Cluster Muscular Dystrophy Drug Development Pipeline Review, 2017 | Now Available at Researchmoz.us here
News-ID: 680035 • Views: …
More Releases from Researchmz.us
Global Diabetes Drugs Market Is Expected To Be Worth US$58.4 Bn By The End Of 20 …
Researchmoz added Most up-to-date research on "Diabetes Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025" to its huge collection of research reports.
This report on the Diabetes drugs market analyzes the current and future scenario of the global market. Rise in private and public funding for diabetes drugs, rising prevalence of diabetes, and favorable regulatory scenario for new drug launch are boosting the growth…
Analog Linear and Mixed-Signal Devices Sales Global Market Research Report 2017 …
Researchmoz added Most up-to-date research on "Global Analog Linear and Mixed-Signal Devices Sales Market Report 2017" to its huge collection of research reports.
In this report, the global Analog Linear and Mixed-Signal Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split global into several…
Global Digital Patient Monitoring Device Market Professional Survey Report 2017 …
Researchmoz added Most up-to-date research on "Global Digital Patient Monitoring Device Market Professional Survey Report 2017" to its huge collection of research reports.
This report studies Digital Patient Monitoring Device in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
This report focuses on top manufacturers in global market, with…
Recent Survey Reveals Global Huber Needles Market In Terms Of Market Size, Y-o-Y …
Researchmoz added Most up-to-date research on "Global Market Study on Huber Needles: Asia Pacific to Register a Robust CAGR of 8.1% Between 2016 and 2024" to its huge collection of research reports.
global Huber Needles market over an eight-year period in a newly published report. The main objective of the report is to identify key dynamics influencing the global Huber Needles market during the forecast period (20162024) and provide recent updates…
More Releases for Muscular
Limb Girdle Muscular Dystrophy Pipeline Insight 2025: Advancing Genetic and Rege …
DelveInsight's "Limb Girdle Muscular Dystrophy (LGMD) - Pipeline Insight, 2025" report provides a deep dive into the evolving therapeutic landscape of LGMD, a group of genetically inherited muscular disorders characterized by progressive weakness in the hip and shoulder muscles. With more than 25 active pipeline candidates targeting various LGMD subtypes, the field is witnessing a shift toward personalized gene therapies and precision treatments.
Recent advances have focused on gene replacement, exon…
Evolving Market Trends In The Spinal Muscular Atrophy Industry: Revolutionizing …
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
What Is the Expected Spinal Muscular Atrophy Market Size During the Forecast Period?
Recent years have witnessed a swift expansion of the spinal muscular atrophy market size. The market is projected to surge from $3.53 billion in 2024 to $4.01 billion in 2025, escalating at a compound annual growth rate (CAGR) of 13.5%. The…
Duchenne Muscular Dystrophy Treatmcent Market
Global Duchenne Muscular Dystrophy Treatmcent Market Set for Robust Growth During Forecast Period
The global Duchenne Muscular Dystrophy Treatment Market is poised to witness significant growth at a high Compound Annual Growth Rate (CAGR) during the forecast period of 2023 to 2030. Duchenne muscular dystrophy (DMD) stands as a genetic disorder marked by progressive muscle degeneration and weakness, with therapeutics aimed at addressing the absence of dystrophin, a crucial protein in…
Becker Muscular Dystrophy Market Research Report 2032
DelveInsight's "Becker Muscular Dystrophy Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Becker Muscular Dystrophy (BMD), historical and forecasted epidemiology as well as the Becker Muscular Dystrophy (BMD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Becker Muscular Dystrophy (BMD) is an inherited muscle structure disorder that results in progressive deterioration of limbs, cardiac and skeletal muscles. However,…
Increasing cases of Spinal Muscular Atrophy will accelerate the Spinal Muscular …
Precision Business Insights published a research report on "Spinal Muscular Atrophy Management Market: By Type of Disease (Type-I, Type-II, Type-III, Type-IV), By Management (Gene Therapy, Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), and Geography- Global/Region/Country Forecast to 2027", The Global Muscular Atrophy Management Market is anticipated to grow at considerable level during forecast period 2021-2027. Spinal Muscular Atrophy Management Market was valued at USD 1.3 Billion in 2020…
Spinal Muscular Atrophy Market is Driven by Rising Number of People Affected wit …
The global spinal muscular atrophy market witnesses substantial competition with the presence of a considerable number of market participants of varying sizes, says Transparency Market Research (TMR) in a new market study.
Read Report Overview - https://www.transparencymarketresearch.com/spinal-muscular-atrophy-market.html
Savvy players are engaged in developing novel drug formulations, the success rate of which impacts market share, and trust of these companies among consumers. For such initiatives, large players are partnering with regional companies to…
